第一单位:
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.;Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
作者:
Alan H,Shih [1]
;
Cem,Meydan [2]
;
Kaitlyn,Shank [3]
;
Francine E,Garrett-Bakelman [4]
;
Patrick S,Ward [5]
;
Andrew M,Intlekofer [6]
;
Abbas,Nazir [3]
;
Eytan M,Stein [7]
;
Kristina,Knapp [8]
;
Jacob,Glass [9]
;
Jeremy,Travins [10]
;
Kim,Straley [10]
;
Camelia,Gliser [10]
;
Christopher E,Mason [11]
;
Katharine,Yen [10]
;
Craig B,Thompson [12]
;
Ari,Melnick [13]
;
Ross L,Levine [14]
作者单位:
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.;Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
[1]
Department of Medicine/Hematology-Oncology and Department of Pharmacology, Weill Cornell Medical College, New York, New York.;Department of Physiology and Biophysics and the HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medical College, New York, New York.
[2]
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
[3]
Department of Medicine/Hematology-Oncology and Department of Pharmacology, Weill Cornell Medical College, New York, New York.
[4]
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York.
[5]
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York.;Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
[6]
Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
[7]
Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, New York.
[8]
Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.;Department of Medicine/Hematology-Oncology and Department of Pharmacology, Weill Cornell Medical College, New York, New York.
[9]
Agios Pharmaceuticals, Cambridge, Massachusetts.
[10]
Department of Physiology and Biophysics and the HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medical College, New York, New York.
[11]
Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York.;Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, New York.
[12]
Department of Medicine/Hematology-Oncology and Department of Pharmacology, Weill Cornell Medical College, New York, New York. leviner@mskcc.org amm2014@med.cornell.edu.
[13]
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. leviner@mskcc.org amm2014@med.cornell.edu.;Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.;Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, New York.;Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.
[14]
DOI
10.1158/2159-8290.CD-16-1049
PMID
28193779
发布时间
2026-03-06